TidalSense, formerly Cambridge Respiratory Innovations, is a venture-backed respiratory technology company founded in 2013 and headquartered in Cambridge UK.
Its technologies are built on the foundation of our novel patented sensor technology, embedded within N-Tidal, which provides unprecedented insight into lung physiology through high accuracy, and rapid sampled CO2, unlike anything seen before in clinical medicine.
The platform converts N-Tidal CO2 data into over 80 sensitive respiratory biomarkers, in real-time, through analysis of waveform geometry, which fuels its AI diagnostic and monitoring technologies.